Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - European heart journal, 2019 - academic.oup.com
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.

P Giral, A Neumann, A Weill, J Coste - European Heart Journal, 2019 - europepmc.org
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[HTML][HTML] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neuman, A Weill, J Coste - Eur Heart J, 2019 - iforumrx.org
Older adults—more than 14 million Americans age 75 years and older 1—face a dilemma.
They are at high risk for atherosclerotic cardiovascular disease (ASCVD) due to endothelial …

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill… - European Heart …, 2019 - hal.sorbonne-universite.fr
AIMS: The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[PDF][PDF] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - European Heart Journal, 2019 - academic.oup.com
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill… - European heart …, 2019 - pubmed.ncbi.nlm.nih.gov
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[PDF][PDF] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill… - European Heart …, 2019 - pdfs.semanticscholar.org
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[PDF][PDF] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - saigaiin.sakura.ne.jp
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[HTML][HTML] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - European Heart Journal, 2019 - ncbi.nlm.nih.gov
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …

[PDF][PDF] Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France

P Giral, A Neumann, A Weill, J Coste - European Heart Journal, 2019 - scienceopen.com
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …